Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

266
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
266
Prevalence and Incidence01:08

Prevalence and Incidence

815
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
815
Biostatistics: Overview01:20

Biostatistics: Overview

365
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
365
Actuarial Approach01:20

Actuarial Approach

135
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
135
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

536
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
536
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

612
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
612

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Overview and Recent Developments in the Analysis of Multistate Processes.

Statistics in medicine·2026
Same author

Mastering rare event analysis: subsample-size determination in Cox and logistic regressions.

Biometrics·2025
Same author

Discrete-time competing-risks regression with or without penalization.

Biometrics·2025
Same author

Isolated Hydronephrosis and Urinary Tract Infection by Two Years of Age: A Population-Based Study.

The Journal of pediatrics·2024
Same author

The killifish germline regulates longevity and somatic repair in a sex-specific manner.

bioRxiv : the preprint server for biology·2024
Same author

Extreme Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA): a discrete group of patients.

Pediatric rheumatology online journal·2023
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Sep 12, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Cumulative incidence function estimation using population-based biobank data.

Malka Gorfine1, David M Zucker2, Shoval Shoham1

  • 1Department of Statistics and Operations Research, Tel Aviv University, Tel Aviv 69978, Israel.

Biometrics
|August 4, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a new method to analyze biobank data, improving the estimation of disease incidence by efficiently including prevalent cases. This enhances research efficiency and allows for earlier age-based disease onset analysis.

Keywords:
Aalen–Johansen estimatordelayed entryillness–death modelleft truncationsurvival analysis

More Related Videos

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

6.7K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Related Experiment Videos

Last Updated: Sep 12, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

6.7K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Area of Science:

  • Epidemiology
  • Biostatistics
  • Biobanking Research

Background:

  • Population-based biobanks are crucial for large-scale epidemiological and clinical research.
  • Utilizing biobank data presents unique challenges, particularly with prevalent cases and age-related cohort entry.
  • Existing methods struggle to efficiently incorporate prevalent disease data and estimate incidence at early ages.

Purpose of the Study:

  • To develop a novel cumulative incidence function (CIF) estimator for biobank data.
  • To efficiently incorporate prevalent cases into CIF estimation.
  • To enable CIF estimation for disease onset ages below the lower recruitment limit ($c_L$).

Main Methods:

  • Development of a new cumulative incidence function (CIF) estimator.
  • Incorporation of prevalent disease data (individuals with disease at recruitment).
  • Analysis of individuals recruited as healthy with disease onset during follow-up.

Main Results:

  • The proposed CIF estimator demonstrates increased statistical efficiency.
  • The method successfully provides CIF estimates for disease onset ages prior to the cohort's lower age limit ($c_L$).
  • Enhanced ability to analyze disease incidence across a wider age range using biobank data.

Conclusions:

  • The novel CIF estimator offers significant advantages for biobank data analysis.
  • Improved efficiency and expanded age range for incidence estimation are key benefits.
  • This method advances epidemiological research using large-scale biobank resources.